Your browser doesn't support javascript.
loading
Surgery for obstructive hypertrophic cardiomyopathy: challenge and future / 中华外科杂志
Chinese Journal of Surgery ; (12): 181-186, 2023.
Artículo en Chino | WPRIM | ID: wpr-970178
ABSTRACT
After more than 60 years of development, with the deepening of the pathophysiological understanding of obstructive hypertrophic cardiomyopathy, the extent and resection thickness of myectomy have increased significantly. Myectomy combined with the correction of anomalies of the mitral valve apparatus has become the standard treatment of obstructive hypertrophic cardiomyopathy. Only a few centers worldwide can routinely perform it due to the difficulty. Because of the advances of new drugs and interventional therapy, the development of surgical treatment faces many challenges. At the same time, generations of cardiovascular surgeons are constantly trying to promote septal myectomy, including developing devices and the surgical field, as well as improving surgical planning by advanced technology. At present, the superior long-term efficacy of septal myectomy has been confirmed. It is necessary to work together to promote the treatment of hypertrophic obstructive cardiomyopathy, so as to guard people's health.
Asunto(s)
Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Cardiomiopatía Hipertrófica / Resultado del Tratamiento / Tabiques Cardíacos / Válvula Mitral / Insuficiencia de la Válvula Mitral Límite: Humanos Idioma: Chino Revista: Chinese Journal of Surgery Año: 2023 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Cardiomiopatía Hipertrófica / Resultado del Tratamiento / Tabiques Cardíacos / Válvula Mitral / Insuficiencia de la Válvula Mitral Límite: Humanos Idioma: Chino Revista: Chinese Journal of Surgery Año: 2023 Tipo del documento: Artículo